Pier Simari
Bionano’s Breakthrough Moment $BNGO (BioNano Genomics Inc) Support the reverse split on January 15 to secure Bionano Genomics’ future. A rare chance to invest in a revolutionary technology at a turning point. Investing in Bionano Genomics at its current low share price presents a unique opportunity for forward-thinking investors. $NSDQ100 $DJ30 $NSDQ100 $SPX500 The company’s Optical Genome Mapping (OGM) technology is poised to revolutionize the genomics industry, with significant potential to disrupt traditional diagnostic methods in genetic diseases, hereditary disorders, and cancer. On January 15, the company will hold a crucial meeting to decide on a reverse stock split, proposing ratios of either 1:25 or 1:75. This measure is essential to bring the share price above the critical threshold of €1, thereby avoiding the risk of delisting and ensuring Bionano’s ability to attract broader market interest and funding. The reverse split is a necessary step to resolve the company’s current challenges and position it for future growth. By supporting this measure, bondholders and investors can play a key role in helping the company move past this impasse and unlock its long-term potential. As Bionano transitions its technology from research to clinical diagnostics over the next 5-10 years, shareholders who act now stand to gain significantly from the anticipated growth and market demand. This is a rare chance to be part of a transformative technology at a pivotal moment in its journey.
null
.